Beacon Biosignals
Health
· Headquartered in USA 🇺🇸
Track Beacon Biosignals
— get Health deals in free daily digest
Overview
Beacon Biosignals has raised $86 million in an oversubscribed Series B funding round, led by Innoviva and Google Ventures, among others. The company develops AI-powered biomarkers for neurological and psychiatric diseases, aiming to enhance clinical adoption and precision medicine. Total funding now exceeds $121 million.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: Innoviva, Google Ventures
Beacon Biosignals has raised $86 million in an oversubscribed Series B funding round, led by Innoviva and Google Ventures, among others. The company develops AI-powered biomarkers for neurological and psychiatric diseases, aiming to enhance clinical adoption and precision medicine. Total funding now exceeds $121 million.